These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2514 related articles for article (PubMed ID: 18851928)
1. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Dalmau J; Gleichman AJ; Hughes EG; Rossi JE; Peng X; Lai M; Dessain SK; Rosenfeld MR; Balice-Gordon R; Lynch DR Lancet Neurol; 2008 Dec; 7(12):1091-8. PubMed ID: 18851928 [TBL] [Abstract][Full Text] [Related]
3. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Irani SR; Bera K; Waters P; Zuliani L; Maxwell S; Zandi MS; Friese MA; Galea I; Kullmann DM; Beeson D; Lang B; Bien CG; Vincent A Brain; 2010 Jun; 133(Pt 6):1655-67. PubMed ID: 20511282 [TBL] [Abstract][Full Text] [Related]
4. Anti-NMDA-receptor encephalitis: a cause of psychiatric, seizure, and movement disorders in young adults. Vincent A; Bien CG Lancet Neurol; 2008 Dec; 7(12):1074-5. PubMed ID: 18851929 [No Abstract] [Full Text] [Related]
6. [Psychiatric symptoms of a paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis: A case report]. Le Foll J; Pelletier A Encephale; 2010 Apr; 36(2):166-71. PubMed ID: 20434635 [TBL] [Abstract][Full Text] [Related]
9. [Clinical features and pathogenesis of anti-NMDA receptor encephalitis]. Iizuka T Rinsho Shinkeigaku; 2008 Nov; 48(11):920-2. PubMed ID: 19198118 [TBL] [Abstract][Full Text] [Related]
10. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Iizuka T; Sakai F; Ide T; Monzen T; Yoshii S; Iigaya M; Suzuki K; Lynch DR; Suzuki N; Hata T; Dalmau J Neurology; 2008 Feb; 70(7):504-11. PubMed ID: 17898324 [TBL] [Abstract][Full Text] [Related]
11. Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. Seki M; Suzuki S; Iizuka T; Shimizu T; Nihei Y; Suzuki N; Dalmau J J Neurol Neurosurg Psychiatry; 2008 Mar; 79(3):324-6. PubMed ID: 18032452 [TBL] [Abstract][Full Text] [Related]
12. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy. Levite M J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016 [TBL] [Abstract][Full Text] [Related]
14. Anti-N-methyl-D-aspartate receptor encephalitis with serum anti-thyroid antibodies and IgM antibodies against Epstein-Barr virus viral capsid antigen: a case report and one year follow-up. Xu CL; Liu L; Zhao WQ; Li JM; Wang RJ; Wang SH; Wang DX; Liu MY; Qiao SS; Wang JW BMC Neurol; 2011 Nov; 11():149. PubMed ID: 22126669 [TBL] [Abstract][Full Text] [Related]
15. Anti-N-methyl-D-aspartate receptor encephalitis associated with an ovarian teratoma in an adolescent female. Lesher AP; Myers TJ; Tecklenburg F; Streck CJ J Pediatr Surg; 2010 Jul; 45(7):1550-3. PubMed ID: 20638543 [TBL] [Abstract][Full Text] [Related]
16. [Unique clinical features and pathophysiology of anti-NMDA receptor encephalitis]. Iizuka T Rinsho Shinkeigaku; 2009 Nov; 49(11):774-8. PubMed ID: 20030207 [TBL] [Abstract][Full Text] [Related]
17. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Petit-Pedrol M; Armangue T; Peng X; Bataller L; Cellucci T; Davis R; McCracken L; Martinez-Hernandez E; Mason WP; Kruer MC; Ritacco DG; Grisold W; Meaney BF; Alcalá C; Sillevis-Smitt P; Titulaer MJ; Balice-Gordon R; Graus F; Dalmau J Lancet Neurol; 2014 Mar; 13(3):276-86. PubMed ID: 24462240 [TBL] [Abstract][Full Text] [Related]
18. Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis. Mikasova L; De Rossi P; Bouchet D; Georges F; Rogemond V; Didelot A; Meissirel C; Honnorat J; Groc L Brain; 2012 May; 135(Pt 5):1606-21. PubMed ID: 22544902 [TBL] [Abstract][Full Text] [Related]